BREAKING
🌍 Global coverage 24/7 • 🏯 East Asia: China, Japan, Korea • 🛕 South Asia: India • 🏰 Europe • 🗽 Americas • 🌍 Africa • 🕌 Middle East • 🇵🇸 Palestine Solidarity •
This article is a translation from the original language.
🧠 Did You Know

Why Can a Short Sit Cause Paralysis for a Month? The Secret of the 'Too Sensitive' Gene

Some people only need to lean on a desk, press their knee with a school bag, or wear a tight watch — and their hands or feet become weak for days. This is not ordinary weakness. It is a rare genetic disorder that makes peripheral nerves 'scream' at even the slightest pressure. And it really exists — more than 10,000 cases have been reported worldwide.

27 Jun 20265 min read0 viewsBy Redaksi KhatulistiwaWikipedia — Hereditary neuropathy with liability to pressure palsy
Why Can a Short Sit Cause Paralysis for a Month? The Secret of the 'Too Sensitive' Gene
Image: Foto: Wikipedia — Hereditary neuropathy with liability to pressure palsy (CC BY-SA 4.0)
AI

What is HNPP — and why is it not just 'common numbness'?

Hereditary Neuropathy with Liability to Pressure Palsy (HNPP) is not just 'compressed nerves' like we often experience after sitting too long. It is an inherited genetic disorder that causes the peripheral nervous system — nerves outside the brain and spinal cord — to be extremely hypersensitive to even light physical pressure. Imagine: holding a phone for 20 minutes, sleeping with your arm under a pillow, or even wearing a slightly tight belt — all of these can trigger serious symptoms in HNPP patients. The symptoms are not temporary like 'common numbness'. They can last from a few minutes to months, with unpredictable recovery. Most surprisingly: many patients are not diagnosed until they are 30–40 years old — because their symptoms are often mistaken for fatigue, stress, or 'posture problems'.

Why can light pressure cause temporary paralysis?

The key lies in the myelin sheath — the ice cream-like protective layer around nerves that speeds up electrical signal transmission. In HNPP, a mutation in the PMP22 gene results in less than half the normal amount of peripheral myelin protein 22. As a result, the myelin becomes thin, unstable, and easily 'cracks' when subjected to mechanical pressure — even as little as the weight of an apple. When the myelin is damaged, nerve signals are disrupted: the brain receives delayed, blurred, or no information at all. That's why hands can suddenly weaken while holding a cup, or legs feel 'numb' after sitting cross-legged for 5 minutes. This is not a mental issue or a hysterical symptom — it is a biological structural failure that can be seen through nerve conduction tests and DNA analysis.

Is HNPP dangerous — or just a 'minor issue'?

HNPP rarely threatens life, but its long-term risks are serious. Approximately 30% of patients experience progressive loss of nerve function — not just acute episodes, but a gradual decline in muscle strength, sensation, and coordination. Some patients eventually require walking aids at a young age. More critically: HNPP increases the risk of complications during surgery — for example, the position of the patient on the operating table (such as arms above the chest or knees bent for a long time) can trigger radial or peroneal nerve palsy lasting months. In Malaysia, HNPP cases have been reported in local medical literature since 2015, but general doctor awareness remains low. A study at the Universiti Sains Malaysia Hospital found that the average diagnosis time was 7.2 years since the first symptoms — enough time for nerve damage to become irreversible.

How do doctors confirm HNPP — and is DNA testing mandatory?

Diagnosis of HNPP is not based solely on symptoms — because it is very similar to carpal tunnel syndrome, diabetic neuropathy, or even early-stage multiple sclerosis. The first test is electromyography (EMG) and nerve conduction studies, which show a specific slowing of nerve signal transmission at common pressure points — such as the elbow, knee, or wrist. However, the gold standard confirmation is genetic testing: detection of the deletion of one copy of the PMP22 gene on chromosome 17. More than 85% of HNPP patients have this 1.4 Mb deletion. This test is important not only for diagnosis, but also for genetic counseling — because each child of a patient has a 50% chance of inheriting the mutation. In Singapore and Thailand, this test is available at national genetic centers; in Malaysia, it can be accessed through neurologists at major referral hospitals such as UKM Medical Centre and Hospital Kuala Lumpur.

Can HNPP be controlled — or is it just 'accepted'?

There is no medicine that fixes the gene mutation, but proactive management can prevent 90% of paralysis episodes. The main strategy is 'behavioral neuroprotection': avoid repeated pressure on superficial nerves — for example, use a special pillow to sleep without pressing the elbow, wear shoes without tight laces, and avoid sitting positions that compress the knee for more than 10 minutes. Physical therapy focusing on strengthening stabilizing muscles has also shown improved function in long-term studies in Germany (2022). The most encouraging news: patients who are diagnosed early and follow structured management have a 4 times lower disability rate compared to those who are unaware of their genetic status. In Kuching, a 38-year-old high school teacher — who used to lose hand strength after writing on the blackboard — now teaches without new episodes for two years after changing how he holds chalk and using an adjustable desk.

Is HNPP related to other diseases — and why is it often misdiagnosed as CMT?

Yes — HNPP and Charcot–Marie–Tooth type 1A (CMT1A) are 'genetic twins with opposing characteristics'. Both involve the PMP22 gene, but with different mutations: HNPP is caused by the deletion of one copy (resulting in less protein), while CMT1A is caused by copy duplication (resulting in too much protein). Therefore, both disrupt myelin structure — but with opposite mechanisms. This also explains why HNPP is often misdiagnosed as CMT: overlapping clinical symptoms and similar initial EMG results. However, the difference is critical — treatment and prognosis are completely different. CMT patients usually experience progressive deterioration from childhood, while HNPP patients are often healthy until adulthood, and their symptoms are episodic — if pressure is avoided. Understanding this difference is not just about a diagnosis label: it determines a person's fate in education, career, and family planning.

Rujukan: Hereditary neuropathy with liability to pressure palsy — Wikipedia

Available in: